REPRESENTATION AND EQUITY IN UTILITY ASSESSMENTS USED FOR COST-EFFECTIVENESS ANALYSES

被引：0
|
作者：
Predmore, Z. [1 ]
Huilgol, S. [1 ]
Frank, L. [2 ]
Concannon, T. [1 ]
机构：
[1] RAND Corp, Boston, MA 02116 USA
[2] RAND Corp, Santa Monica, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR75
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [31] The Challenges of Cost-Effectiveness Analyses for the Clinician
    Erickson, Kevin F.
    Winkelmayer, Wolfgang C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (06) : 1023 - 1025
  • [32] In Brief: Cost-effectiveness Analyses in Orthopaedics
    Vavken, Patrick
    Bianchi, Thomas
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (08) : 2395 - 2398
  • [33] Recommendations for reporting cost-effectiveness analyses
    Siegel, JE
    Weinstein, MC
    Russell, LB
    Gold, MR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1339 - 1341
  • [34] Statistical issues in cost-effectiveness analyses
    Thompson, S
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2002, 11 (06) : 453 - 454
  • [35] Cost-effectiveness and cost-utility evaluations in radiology
    d'Othée, BJ
    Bettmann, MA
    Pirard, S
    Zhuang, Z
    Black, WC
    JOURNAL DE RADIOLOGIE, 2001, 82 (12): : 1687 - 1692
  • [36] What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses
    Picavet, E.
    Cassiman, D.
    Simoens, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 304 - 307
  • [37] POTENTIAL INCONSISTENCIES BETWEEN COST-EFFECTIVENESS AND COST-UTILITY ANALYSES - AN UPSTAIRS DOWNSTAIRS SOCIOECONOMIC DISTINCTION
    RITTENHOUSE, BE
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1995, 11 (02) : 365 - 376
  • [38] Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses
    Hendrix, Nathaniel
    Kim, David D.
    Patel, Krishna S.
    Devine, Beth
    MEDICAL DECISION MAKING, 2021, 41 (03) : 366 - 372
  • [39] Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods
    Ngo, Preston J.
    Cressman, Sonya
    Behar-Harpaz, Silvia
    Karikios, Deme J.
    Canfell, Karen
    Weber, Marianne F.
    LUNG CANCER, 2022, 166 : 122 - 131
  • [40] COST-EFFECTIVENESS AND COST-BENEFIT ANALYSES OF VACCINES
    WILLEMS, JS
    SANDERS, CR
    JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (05): : 486 - 493
12345